Content is free to use but usage restrictions apply. Please visit our FAQ for conditions of use. If you click download/embed, you acknowledge that you have read and will respect the terms of use.
The European Medicines Agency (EMA) says blood clots should be listed as a "very rare" side effect of the Johnson & Johnson COVID vaccine. What we know about the jab and similar AstraZeneca shot:
A European Medicines Agency recommendation that a type of blood clot should be listed as a "very rare side effect" of the AstraZeneca jab stopped just short of saying there is a causal link with the vaccine
Fears of what is causing the 'highly untypical' blood clots seen in some people vaccinated against Covid-19 have undermined confidence in the AstraZeneca vaccine